NDC 73116-102

FARYDAK

Panobinostat

FARYDAK is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Secura Bio, Inc.. The primary component is Panobinostat Lactate.

• Product ID: 73116-102_8368e056-cfe2-4f4b-8033-dd7e14689eaf
• NDC: 73116-102
• Product Type: Human Prescription Drug
• Proprietary Name: FARYDAK
• Generic Name: Panobinostat
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2015-02-23
• Marketing Category: NDA / NDA
• Application Number: NDA205353
• Labeler Name: Secura Bio, Inc.
• Substance Name: PANOBINOSTAT LACTATE
• Active Ingredient Strength: 20 mg/1
• Pharm Classes: Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 73116-102-06

1 BLISTER PACK in 1 CARTON (73116-102-06) > 6 CAPSULE in 1 BLISTER PACK

• Marketing Start Date: 2015-02-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 73116-102-06 [73116010206]

FARYDAK CAPSULE

• Marketing Category: NDA
• Application Number: NDA205353
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2015-02-23

Drug Details

Active Ingredients

Ingredient	Strength
PANOBINOSTAT LACTATE	20 mg/1

Pharmacological Class

• Histone Deacetylase Inhibitor [EPC]
• Histone Deacetylase Inhibitors [MoA]
• Cytochrome P450 2D6 Inhibitors [MoA]

NDC Crossover Matching brand name "FARYDAK" or generic name "Panobinostat"

NDC	Brand Name	Generic Name
0078-0650	FARYDAK	panobinostat
0078-0651	FARYDAK	panobinostat
0078-0652	FARYDAK	panobinostat
73116-100	FARYDAK	panobinostat
73116-101	FARYDAK	panobinostat
73116-102	FARYDAK	panobinostat